Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
EBM Methods Verdicts
Last year we launched the EBM Methods Verdicts as part of an attempt to keep on top of developments in statistics that will impact on the way we do research.1 2 We focused on statistical methods and in particular on the output from five different journals: Journal of Clinical Epidemiology, Statistics in Medicine, Statistical Methods in Medical Research, BMC Medical Research Methodology and Biostatistics.
The idea is simple: identify papers that we believe are likely to change the way we analyse or report evidence syntheses, randomised trials or studies related to diagnosis, prognosis or monitoring. Our editorial team typically focuses on one of these per month and aims to write a short commentary with a ‘verdict’ explaining how this will change how we do things. We are also interested in people submitting proposals for similar short pieces.
Machine learning—more weapons in the armoury
Bayesian neural networks were the rage in the early 90s. Work in this area seemed to go quiet for most of the 00s but has exploded back into our consciousness in the last few years. This is clear by the number of papers published on the topic (figure 1) with nearly half of the total appearing in the last 2 …
Twitter @rafaoxford, @Oke_jason
Contributors RP, JO, and TRF agreed on the general structure and content of the editorial. All three drafted different parts of the text and edited the final version. They are all equally responsible for the content.
Competing interests RP received funding from the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, the NIHR Oxford Medtech and In-Vitro Diagnostics Co-operative, the NIHR Applied Research Collaboration Oxford and Thames Valley, and the Oxford Martin School. TRF received funding from the NIHR Community Healthcare MedTech and In Vitro Diagnostics Co-operative at Oxford Health NHS Foundation Trust.
Patient consent for publication Not required.
Provenance and peer review Commissioned; internally peer reviewed.